Ultragenyx Pharmaceutical Series A Financing
Jun 20, 2011OUTCOME: Deal Closed
Represented the Company in its $45 million Series A financing to support the development of rare disease therapeutics. The co-lead investors were TPG Biotech and Fidelity Biosciences, joined by Europea ... n investor HealthCap, and Pappas Ventures.
